Table 1.
Search strategy across alternative databases (queries run on October 14, 2016).
| Set | Medline (via PubMed) |
|---|---|
| 1 | #1 Lurasidone Hydrochloride [MeSH Major Topic]∗ |
| 2 | #2 review[Publication Type] OR meta-analysis[Publication Type] |
|
| |
| 3 | Sets 1-2 were combined with “OR” |
|
| |
| 4 | Bipolar disorder |
| 5 | Depression |
|
| |
| 6 | Sets 1–5 were combined with “OR” & “AND” |
|
| |
| Most permissive (generic PubMed - no MeSH headings) | ((Lurasidone) AND Bipolar) AND review[Publication Type] |
|
| |
| Embase | |
|
| |
| Most permissive | #1 “lurasidone”/exp OR lurasidone AND “bipolar depression”:ab,ti AND review:it |
|
| |
| Scopus | |
|
| |
| Most permissive | (TITLE-ABS-KEY (lurasidone) AND TITLE-ABS-KEY (bipolar disorder)) AND DOCTYPE (re) |
|
| |
| Cochrane Library | |
|
| |
| Most permissive | “Lurasidone in Title, Abstract, Keywords and ‘bipolar disorder' in Title, Abstract, Keywords and ‘review' in Publication Type ” |
Note. Words written in italic were used as MeSH headings; the others were used as free text.
∗Proposed entry terms, then accounted as free text integrations:
Hydrochloride, Lurasidone
Lurasidone HCl
HCl, Lurasidone
SM 13496
13496, SM
SM13496
SM-13496
SM-13,496
SM 13,496
SM13,496
Lurasidone
N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3 bicyclo(2.2.1)heptanedicarboximide
Latuda.